GlassScriptPhysician profile
David Beaton Comulada
NPI 1194176578
$28,853.80
in general payments reported to CMS, 2019-2025
10 companies · $2,450 in 2025
The $2,450 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15K · 2024: $11K · 2025: $2,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Travel and Lodging: $5,673 · Education: $4,763 · Food and Beverage: $3,543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $14,875.00 |
| Travel and Lodging | $5,672.98 |
| Education | $4,763.00 |
| Food and Beverage | $3,542.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $13,740.90 | 2023-2024 | |
| Smith+Nephew, INC. | $6,273.74 | 2023-2025 | Legion Revision, Redapt, Bone Anchors With Arthroscopic Delivery System |
| Rmc Orthopedic & Surgical, INC. | $3,366.00 | 2024-2025 | |
| Stryker Corporation | $2,098.32 | 2023-2025 | Iconix, Blueprint Patient Specific Instrumentation, Mako |
| Medical Device Business Services, INC. | $2,071.87 | 2024 | Rigidloop |
| Zimmer Biomet Holdings, INC. | $693.00 | 2023-2024 | Oss Orthopedic Salvage System |
| Linvatec Corporation | $335.96 | 2023-2024 | Biobrace 23mm, Linvatec Shoulder Arthroscopy |
| Gotham Surgical Solutions & Devices, INC. | $138.29 | 2023 | |
| Johnson and Johnson International | $85.72 | 2025 | Ethicon, Echelon; Endopath |
| Vericel Corporation | $50.00 | 2024 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Beaton Comulada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.